Sinopharm and Sputnik V: Heavy Debate Might Conclude with EU Authorization The Chinese Sinopharm and Russian Sputnik V vaccines are increasingly receiving both positive and negative attention from the European Union. While the European Commission is supposedly planning to recognize vaccines with emergency authorization in the EU’s vaccine passport, an official from the European Medicines Agency (EMA) has warned against doing so, citing a lack of documentation. The two vaccines could play a stronger role in Europe, as they have helped Hungary reach a vaccination rate high above the EU average. The European Commission is already working on a European digital vaccine passport which, unlike Hungarian vaccination certificates, contains the type of vaccine used for inoculation.